Crossmark

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Published Online: 2018-05-02

Published Print: 2018-12

Authors

Tang, Fei http://orcid.org/0000-0003-1475-5028
Zheng, Pan
Funding

Funding for this research was provided by:

National Institute on Aging (AG036690)

National Institute of Allergy and Infectious Diseases (AI64350)
License Information

Text and Data Mining valid from 2018-05-02

Version of Record valid from 2018-05-02
More Information

Article History

Received: 24 March 2018

Accepted: 25 April 2018

First Online: 2 May 2018

Document is current